Company Alzheon, Inc.
Equities
ALZH
US00168L1017
Biotechnology & Medical Research
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Tolar
FOU | Founder | 59 | 13-05-31 |
Kenneth A. Mace
DFI | Director of Finance/CFO | 52 | 15-08-31 |
Adem Albayrak
COO | Chief Operating Officer | - | 21-09-12 |
Susan Abushakra
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-06-30 |
John A. Hey
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
John J. Haas
LAW | General Counsel | 48 | - |
Aidan Power
PRN | Corporate Officer/Principal | - | 15-05-31 |
Petr Kocis
PRN | Corporate Officer/Principal | - | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jordan Heller
BRD | Director/Board Member | 62 | 20-01-07 |
Chairman | 80 | 18-08-05 | |
Martin Tolar
FOU | Founder | 59 | 13-05-31 |
Diane Jorkasky
BRD | Director/Board Member | 72 | 19-11-30 |
Christopher Dunn
BRD | Director/Board Member | 64 | 20-01-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,268,967 | 0 | 0 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |